HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

EDAN Instruments Unveils Next-Generation Diagnostic Ultrasound System at Arab Health 2020

By HospiMedica International staff writers
Posted on 13 Nov 2022
Image: Acclarix LX9 (Photo courtesy of Edan Instruments)
Image: Acclarix LX9 (Photo courtesy of Edan Instruments)
EDAN Instruments (Shenzhen, China) unveiled its next-generation diagnostic ultrasound system Acclarix LX9 at Arab Health 2020, the largest healthcare exhibition in the Middle East.

EDAN is a healthcare company that provides a comprehensive line of medical solutions to address a broad range of healthcare practices, including diagnostic ECG, OB/GYN, ultrasound imaging, in-vitro diagnostics, patient monitoring, point-of-care testing, and veterinary.

At Arab Health 2020, EDAN unveiled the new Acclarix LX9 diagnostic ultrasound system featuring a brand new EIS+ platform that presents rich details on a 21.5-inch high-resolution LCD screen for sonographers to take a better look at patients. The LX9 features a slim body and 180-degree rotatable integrated user interface.

At Arab Health this year, EDAN also presented its CTG monitor F15 which supports triplet monitoring, while its wireless TOCO transducer can provide maternal heart rate (MHR) simply by plugging on a cover on top. Its "Transfer" function and 15-minute resume breakpoint function enable the device to be used smoothly during inter-hospital transfer.

"Acclarix LX9 is ushering EDAN's ultrasound imaging into the age of intelligent diagnosis. With the new added advanced features like eOB, eLV, eFollicle, eVolFlow, and eNT, LX9 provides a smart workflow solution, which optimizes the workload of sonographers across multiple departments, including obstetrics, gynecology, cardiology, and general surgery, etc.," said Alice Bai, EDAN's ultrasound clinical application manager.

Related Links:
Edan Instruments

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Hemostatic Agent
HEMOBLAST Bellows

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more